Latest Insider Transactions at Zynerba Pharmaceuticals, Inc. (ZYNE)
This section provides a real-time view of insider transactions for Zynerba Pharmaceuticals, Inc. (ZYNE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Zynerba Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Zynerba Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 03
2021
|
John P. Butler |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+33.33%
|
-
|
|
Aug 03
2021
|
Pamela Stephenson |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Jan 21
2021
|
Suzanne M. Hanlon Sec, VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
37,000
+31.44%
|
-
|
|
Jan 21
2021
|
Brian Rosenberger VP, Commercial & Business Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
37,000
+50.0%
|
-
|
|
Jan 21
2021
|
Terri B Sebree President |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+22.31%
|
-
|
|
Jan 21
2021
|
Armando Anido Chairman & Chief Exec. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
107,911
+18.99%
|
-
|
|
Jan 21
2021
|
James E Fickenscher Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,000
+41.69%
|
-
|